The upregulation of ZG16B (Zymogen granule protein 16B) expression correlates to a better prognosis of breast cancer patients [158]; however, ZG16B promotes colorectal cancer progression through the Wnt-β-catenin pathway [159]. This evidence concerns the gene ZG16B and breast carcinoma.